Clinical Trial Update: Carboplatin Periocular Injection for Retinoblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating periocular carboplatin for retinoblastoma; current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Carboplatin (periocular injection) (carboplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinoblastoma | Phase 3 | Status: UNKNOWN